CD274 and breast cancer: There were 137 (45.51%) BC patients, who were PD‐L1‐positive, of which 32.89% (1 ≤ CPS <10) were defined as PD‐L1‐L, while 12.62% (CPS ≥10) were defined as PD‐L1‐H.